{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:47:04Z","timestamp":1785923224585,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012412","name":"Kansai Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaci.2026.04.016","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:27:04Z","timestamp":1777480024000},"page":"521-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hereditary angioedema iPSC models implicate ER-associated degradation as a potential therapeutic target"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-3061","authenticated-orcid":false,"given":"Long Hoang","family":"Luong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizu","family":"Itsukage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Shirouzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tanizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Hitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.04.016_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0002-9343(90)90535-L","article-title":"Hereditary angioedema: its diagnostic and management perspectives","volume":"88","author":"Sim","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2026.04.016_bib2","first-page":"S25","article-title":"The pathophysiology of hereditary angioedema","volume":"3","author":"Zuraw","year":"2010","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2026.04.016_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.iac.2022.10.012","article-title":"Hereditary angioedema","volume":"43","author":"Wilkerson","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2026.04.016_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.alit.2023.04.004","article-title":"Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency","volume":"72","author":"Miyata","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2026.04.016_bib5","first-page":"222","article-title":"Long term outcome of C1-esterase inhibitor deficiency","volume":"42","author":"Long","year":"2024","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.04.016_bib6","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s12325-022-02401-0","article-title":"Hereditary angioedema: diagnosis, clinical implications, and pathophysiology","volume":"40","author":"Sinnathamby","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaci.2026.04.016_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(11)60935-5","article-title":"Hereditary angio-oedema","volume":"379","author":"Longhurst","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.04.016_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI98869","article-title":"Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema","volume":"129","author":"Haslund","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.04.016_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema","volume":"9","author":"Busse","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.04.016_bib10","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014the 2021 revision and update","volume":"77","author":"Maurer","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.04.016_bib11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/TCRM.S3172","article-title":"Treatment of hereditary angioedema with plasma-derived C1 inhibitor","volume":"4","author":"Prematta","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jaci.2026.04.016_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12029-012-9402-5","article-title":"Danazol-induced hepatocellular carcinoma in a patient with hereditary angioedema","volume":"43","author":"Thoufeeq","year":"2012","journal-title":"J Gastrointest Canc"},{"key":"10.1016\/j.jaci.2026.04.016_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2006.12.447","article-title":"Side effects of long-term treatment with danazol and stanozolol in hereditary angioedema","volume":"119","author":"Bork","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.016_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s13023-022-02536-x","article-title":"Long-term prophylaxis with androgens in the management of hereditary angioedema (HAE) in emerging countries","volume":"17","author":"Guo","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaci.2026.04.016_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/gb-2006-7-5-216","article-title":"An overview of the serpin superfamily","volume":"7","author":"Law","year":"2006","journal-title":"Genome Biol"},{"key":"10.1016\/j.jaci.2026.04.016_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00795-004-0281-0","article-title":"Serpinopathy and endoplasmic reticulum stress","volume":"38","author":"Miyata","year":"2005","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.jaci.2026.04.016_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12929-024-01054-1","article-title":"The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy","volume":"31","author":"Gariballa","year":"2024","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jaci.2026.04.016_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4292\/wjgpt.v1.i5.94","article-title":"Z \u03b1-1 antitrypsin deficiency and the endoplasmic reticulum stress response","volume":"1","author":"Greene","year":"2010","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.jaci.2026.04.016_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3389\/fimmu.2016.00547","article-title":"Hereditary angioedema as a metabolic liver disorder: novel therapeutic options and prospects for cure","volume":"7","author":"Ameratunga","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.04.016_bib20","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jaip.2019.02.020","article-title":"Hereditary angioedema may be associated with the development of fatty liver","volume":"7","author":"Al-Qahtani","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.04.016_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.jaci.2026.04.016_bib22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/stem.1293","article-title":"An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells","volume":"31","author":"Okita","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.jaci.2026.04.016_bib23","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","article-title":"Hep G2 is a hepatoblastoma-derived cell line","volume":"40","author":"L\u00f3pez-Terrada","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaci.2026.04.016_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.23354","article-title":"Highly efficient generation of human hepatocyte\u2013like cells from induced pluripotent stem cells","volume":"51","author":"Si-Tayeb","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaci.2026.04.016_bib25","article-title":"Citrin-deficient patient-derived induced pluripotent stem cells as a pathological liver model for congenital urea cycle disorders","volume":"40","author":"Okano","year":"2024","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.jaci.2026.04.016_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jaci.2026.04.016_bib27","doi-asserted-by":"crossref","first-page":"17672","DOI":"10.1074\/jbc.RA120.015398","article-title":"AggreCount: an unbiased image analysis tool for identifying and quantifying cellular aggregates in a spatially defined manner","volume":"295","author":"Klickstein","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2026.04.016_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2026.04.016_bib29","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.str.2016.09.013","article-title":"How dextran sulfate affects C1-inhibitor activity: a model for polysaccharide potentiation","volume":"24","author":"Dijk","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.jaci.2026.04.016_bib30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.5966\/sctm.2015-0250","article-title":"Stem cell surface marker expression defines late stages of reprogramming to pluripotency in human fibroblasts","volume":"5","author":"Pomeroy","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jaci.2026.04.016_bib31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.04.016_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","article-title":"Induced pluripotent stem cells in disease modelling and drug discovery","volume":"20","author":"Rowe","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jaci.2026.04.016_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.reth.2015.07.002","article-title":"Regenerative therapy by fusion of medicine and engineering: first-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: a report of the Symposium of Regenerative Medicine for Patients","volume":"2","author":"Okano","year":"2015","journal-title":"Regen Ther"},{"key":"10.1016\/j.jaci.2026.04.016_bib34","doi-asserted-by":"crossref","unstructured":"Zushin PJH, Mukherjee S, Wu JC. FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J Clin Invest 133:e175824.","DOI":"10.1172\/JCI175824"},{"key":"10.1016\/j.jaci.2026.04.016_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1719056","article-title":"Deciphering reprogramming efficiency in human induced pluripotent stem cells: insights from the generation of 150 cell lines","volume":"16","author":"Kuebler","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.04.016_bib36","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/all.12186","article-title":"Risk of angioedema following invasive or surgical procedures in HAE type I and II--the natural history","volume":"68","author":"Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.04.016_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jaci.2004.06.021","article-title":"C1 inhibitor gene expression in patients with hereditary angioedema: quantitative evaluation by means of real-time RT-PCR","volume":"114","author":"Pappalardo","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.016_bib38","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2023.04.023","article-title":"Restriction of C1-inhibitor activity in hereditary angioedema by dominant-negative effects of disease-associated SERPING1 gene variants","volume":"152","author":"Ry\u00f8","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.016_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/srep40719","article-title":"Androgen mediated regulation of endoplasmic reticulum-associated degradation and its effects on prostate cancer","volume":"7","author":"Erzurumlu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2026.04.016_bib40","first-page":"476","article-title":"Evaluation of danazol therapy for patients with PiZZ alpha-1-antitrypsin deficiency","volume":"134","author":"Wewers","year":"1986","journal-title":"Am Rev Respir Dis"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926002988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926002988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:19:07Z","timestamp":1785921547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926002988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0091674926002988"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.04.016","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary angioedema iPSC models implicate ER-associated degradation as a potential therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}